Regulation of gene expression in human cancers by TRIM24
Related Experiment Video
Updated: Sep 29, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Srikanth Appikonda1, Kaushik N Thakkar2, Michelle Craig Barton2
1Department of Epigenetics and Molecular Carcinogenesis, Center for Cancer Epigenetics, Houston, TX 77030, USA.
Abstract:
Tripartite Motif-containing protein 24 (TRIM24) functions as an E3 ligase targeting p53 for ubiquitination, a histone 'reader' that interacts with a specific signature of histone post-translational modifications and a co-regulator of nuclear receptor-regulated transcription. Although mouse models of Trim24 depletion suggest that TRIM24 may be a liver-specific tumor suppressor, several studies show that human TRIM24 is an oncogene when aberrantly over expressed. This review focuses on the mechanisms of TRIM24 functions in oncogenesis and metabolic reprogramming, which underlie recent interest in therapeutic targeting of aberrant TRIM24 in human cancers.
Insights
Tripartite Motif-containing protein 24 (TRIM24) has dual roles in cancer. While mouse studies suggest it
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- Tripartite Motif-containing protein 24 (TRIM24) exhibits multifaceted functions, including E3 ligase activity against p53, histone modification recognition, and nuclear receptor co-regulation.
- Contrasting evidence exists regarding TRIM24's role in tumorigenesis; mouse models indicate tumor suppression, whereas human studies identify it as an oncogene upon overexpression.
Purpose of the Study:
- To review the mechanistic roles of TRIM24 in oncogenesis.
- To explore TRIM24's involvement in metabolic reprogramming within cancer.
- To highlight the therapeutic potential of targeting aberrant TRIM24 in human cancers.
Main Methods:
- Literature review of existing studies on TRIM24.
- Analysis of TRIM24's molecular functions (E3 ligase, histone reader, co-regulator).
- Synthesis of data on TRIM24's oncogenic and metabolic roles.
Main Results:
- TRIM24's dual function as a potential tumor suppressor (mouse models) and oncogene (human cancers) is highlighted.
- Mechanisms linking TRIM24 to cancer development, including p53 regulation and epigenetic modifications, are discussed.
- TRIM24's contribution to metabolic reprogramming in cancer cells is explored.
Conclusions:
- Aberrant TRIM24 expression is implicated in human oncogenesis and metabolic reprogramming.
- TRIM24 represents a promising therapeutic target for various human cancers.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
03:37Generating the Transcriptional Regulation View of Transcriptomic Features for Prediction Task and Dark Biomarker Detection on Small Datasets
Published on: March 1, 2024
Related Concept Videos
Epigenetic Regulation
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Epigenetic Regulation
X-chromosome...
Regulation of Expression at Multiple Steps